Form D · Venture Capital Fund
Advent Life Sciences Growth Fund LP
London, X0 · CIK 0002040586
Offering snapshot reported Nov 7, 2025 · SEC filing
- Reported sold
- $9.8M Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 14, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 7, 2025 | Amendment | $9,800,250 | $0vs Oct 17, 2024 | 1 | SEC filing |
| Oct 17, 2024 | Initial | $9,800,250 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-527005
Total Amount Sold covers only US sales pursuant to Regulation D. Calculated based on the exchange rate of 1.3067 GBP to $1 USD as of October 11, 2024.
Source: Form D, filed Nov 7, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Advent Life Sciences Llp | Executive, Promoter |
| Kaasim Mahmood | Executive |
| Shahzad Malik | Executive |
| Rajesh Parekh | Executive |
| Dominic Schmidt | Executive, Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:London, X0, W1T 6ES